A metabolic interaction in vivo between cannabidiol and 1 -tetrahydrocannabinol.
作者信息
Jones G, Pertwee R G
出版信息
Br J Pharmacol. 1972 Jun;45(2):375-7. doi: 10.1111/j.1476-5381.1972.tb08092.x.
Abstract
The effect of pretreatment with cannabidiol (CBD; 50 mg/kg i.p.) on the distribution of radioactivity in chromatograms of ethyl acetate extracts of the brains of mice injected with tritiated Delta(1)-tetrahydrocannabinol ((3)H-Delta(1)-THC; 1.0 mg/kg i.v.) was determined. The pretreatment with CBD produced significant increases in the levels of radioactivity in the brain assigned to Delta(1)-THC and its centrally active metabolite 7-hydroxy-Delta(1)-THC: the changes produced were respectively 1.4 and 2.0 fold.Pretreatment with CBD did not bring about any detectable change in the degree of 'catalepsy' produced by Delta(1)-THC. This negative finding may have been due to the wide limits of error that were obtained in the bioassay.
摘要
相似文献
1
A metabolic interaction in vivo between cannabidiol and 1 -tetrahydrocannabinol.
Br J Pharmacol. 1972 Jun;45(2):375-7. doi: 10.1111/j.1476-5381.1972.tb08092.x.
2
Brain levels of delta1-tetrahydrocannabinol and its metabolites in mice tolerant to the hypothermic effect of delta1-tetrahydrocannabinol.
Br J Pharmacol. 1973 Oct;49(2):373-5. doi: 10.1111/j.1476-5381.1973.tb08388.x.
3
3H-delta 9-Tetrahydrocannabinol, 3H-cannabinol and 3H-cannabidiol: penetration and regional distribution in rat brain.
Pharmacol Biochem Behav. 1980 Feb;12(2):217-21. doi: 10.1016/0091-3057(80)90359-7.
4
In vitro metabolic formation of a new metabolite, 6 beta-hydroxymethyl-delta 9-tetrahydrocannabinol from cannabidiol through an epoxide intermediate and its pharmacological effects on mice.
Biol Pharm Bull. 1993 Oct;16(10):1008-13. doi: 10.1248/bpb.16.1008.
5
Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC.
Eur Neuropsychopharmacol. 2017 Dec;27(12):1223-1237. doi: 10.1016/j.euroneuro.2017.10.037. Epub 2017 Nov 10.
6
Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats.
Neuropharmacology. 2004 Dec;47(8):1170-9. doi: 10.1016/j.neuropharm.2004.08.009.
7
Plasma and urine profiles of Delta9-tetrahydrocannabinol and its metabolites 11-hydroxy-Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol after cannabis smoking by male volunteers to estimate recent consumption by athletes.
Anal Bioanal Chem. 2010 Apr;396(7):2493-502. doi: 10.1007/s00216-009-3431-3. Epub 2010 Jan 30.
8
Cannabidiol reverses the reduction in social interaction produced by low dose Delta(9)-tetrahydrocannabinol in rats.
Pharmacol Biochem Behav. 2009 Aug;93(2):91-6. doi: 10.1016/j.pbb.2009.04.010. Epub 2009 Apr 23.
9
Heat exposure of Cannabis sativa extracts affects the pharmacokinetic and metabolic profile in healthy male subjects.
Planta Med. 2012 May;78(7):686-91. doi: 10.1055/s-0031-1298334. Epub 2012 Mar 12.
10
Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.
Br J Pharmacol. 2015 Apr;172(7):1783-91. doi: 10.1111/bph.13024. Epub 2015 Jan 23.
引用本文的文献
1
Acute effects of different types of cannabis on young adult and adolescent resting-state brain networks.
Neuropsychopharmacology. 2024 Sep;49(10):1640-1651. doi: 10.1038/s41386-024-01891-6. Epub 2024 May 28.
2
Cannabinoid Therapeutics in Chronic Neuropathic Pain: From Animal Research to Human Treatment.
Front Physiol. 2021 Nov 30;12:785176. doi: 10.3389/fphys.2021.785176. eCollection 2021.
3
Contribution of the Adenosine 2A Receptor to Behavioral Effects of Tetrahydrocannabinol, Cannabidiol and PECS-101.
Molecules. 2021 Sep 2;26(17):5354. doi: 10.3390/molecules26175354.
4
Cannabis Extract Composition Determines Reinforcement in a Vapor Self-Administration Paradigm.
J Neurosci. 2020 Aug 12;40(33):6264-6266. doi: 10.1523/JNEUROSCI.0814-20.2020.
5
Cannabidiol Adverse Effects and Toxicity.
Curr Neuropharmacol. 2019;17(10):974-989. doi: 10.2174/1570159X17666190603171901.
6
FABP1 controls hepatic transport and biotransformation of Δ-THC.
Sci Rep. 2019 May 20;9(1):7588. doi: 10.1038/s41598-019-44108-3.
7
Hepatotoxicity of a Cannabidiol-Rich Cannabis Extract in the Mouse Model.
Molecules. 2019 Apr 30;24(9):1694. doi: 10.3390/molecules24091694.
8
A randomised controlled trial of vaporised Δ-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects.
Eur Arch Psychiatry Clin Neurosci. 2019 Feb;269(1):17-35. doi: 10.1007/s00406-019-00978-2. Epub 2019 Jan 19.
9
Cannabidiol modulation of antinociceptive tolerance to Δ-tetrahydrocannabinol.
Psychopharmacology (Berl). 2018 Nov;235(11):3289-3302. doi: 10.1007/s00213-018-5036-z. Epub 2018 Sep 20.
10
Single and combined effects of Δ -tetrahydrocannabinol and cannabidiol in a mouse model of chemotherapy-induced neuropathic pain.
Br J Pharmacol. 2017 Sep;174(17):2832-2841. doi: 10.1111/bph.13887. Epub 2017 Jul 27.
本文引用的文献
1
Activity of delta8- and delta9-tetrahydrocannabinol and related compounds in the mouse.
Science. 1971 Apr 9;172(3979):165-7. doi: 10.1126/science.172.3979.165.
2
Binding of delta-1-tetrahydrocannabinol to human plasma proteins.
Biochem Pharmacol. 1970 Sep;19(9):2579-84. doi: 10.1016/0006-2952(70)90007-9.
3
Chemical basis of hashish activity.
Science. 1970 Aug 7;169(3945):611-2. doi: 10.1126/science.169.3945.611.
4
Marihuana chemistry.
Science. 1970 Jun 5;168(3936):1159-66. doi: 10.1126/science.168.3936.1159.
5
Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism.
Br J Pharmacol. 1972 Feb;44(2):250-61.
Zotero 插件